Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Exposure related observations in humans: other data

Currently viewing:

Administrative data

Endpoint:
exposure-related observations in humans: other data
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
4 (not assignable)

Data source

Reference
Reference Type:
publication
Title:
Efficacy of Antiperspirants on Feet
Author:
Darrigrand, A., Reynolds, K., Jackson, R.
Year:
1992
Bibliographic source:
Military Medicine, 157, 5:256, 1992

Materials and methods

Test material

Constituent 1
Chemical structure
Reference substance name:
Aluminum chloride, basic
EC Number:
215-477-2
EC Name:
Aluminum chloride, basic
Cas Number:
1327-41-9
Molecular formula:
General formula: Al(OH)x(Cl)(3-x), with x ranging from 0.1 to 2.3
IUPAC Name:
Aluminum chloride, basic

Results and discussion

Applicant's summary and conclusion

Conclusions:
This study indicates that the use of antiperspirants on the foot will: (1) reduce foot-sweat accumulation and, (2) increase the incidence of irritant
dermatitis. The reduced foot-sweat accumulation may also help to reduce foot blistering during exercise in warm environments. In cold
environments, the reduced foot-sweat accumulation should be a benefit in reducing the incidence of trench foot and frostbite injuries. Future
research should address changing the antiperspirant formula to reduce the incidence of irritant dermatitis and to clarify whether or not
antiperspirants can reduce the occunence of foot blisters.
Executive summary:

Nineteen male soldiers participated in a study of the effectiveness of two antiperspirants (aluminum chlorohydrate and aluminum zirconium tetrachlorohydrex glycine) in reducing foot-sweat accumulation and injuries. Each subject was tested before and after antiperspirant application, with a 1-hour treadmill march at 5.6 km/hour in a warm environment. Both antiperspirants decreased (p<0.05) foot-sweat accumulation over 50%. There was also a tendency, although not statistically significant, for subjects to incur fewer blisters with antiperspirant use. However, the antiperspirants also increased (p<0.05) the incidence of irritant dermatitis. Nevertheless, these data suggest that the application of antiperspirants to the feet has merit in reducing serious foot injuries (blisters, trench foot] exacerbated by wet feet.